日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Illness Experience and Unmet Needs of Pulmonary Tuberculosis Patients: A Meta-Synthesis Guided by the Symptom Experience Model

肺结核患者的疾病体验和未满足的需求:基于症状体验模型的荟萃分析

Yang, Yulan; Yu, Qiaolin; Zhao, Xia; Yao, Rong; Shen, Jing; Jiang, Shasha; Yang, Xiaoyi; Wan, Bin

Advances in medical devices using nanomaterials and nanotechnology: Innovation and regulatory science

利用纳米材料和纳米技术开发医疗器械的进展:创新与监管科学

Lin, Chubing; Huang, Xin; Xue, Yueguang; Jiang, Shasha; Chen, Chunying; Liu, Ying; Chen, Kuan

Osteosarcoma immune microenvironment: cellular struggle and novel therapeutic insights

骨肉瘤免疫微环境:细胞斗争与新型治疗见解

Zhang, Yi; Jiang, Shasha; Lv, Jing; Feng, Wei; Yu, Yan; Zhao, Heping

Multi-omics-driven biomarker discovery in autoimmune diseases: a comprehensive review

多组学驱动的自身免疫疾病生物标志物发现:一项综合综述

Zhang, Yi; Xu, Haofeng; Xu, Lijuan; Jiang, Shasha; Yu, Yan; Zhao, Heping

Plant-derived food bioactives in bone health: from multi-targeted roles to molecular mechanisms in osteoporosis

植物源性食品生物活性物质在骨骼健康中的作用:从多靶点作用到骨质疏松症的分子机制

Zhang, Yi; Xu, Lijuan; Xu, Haofeng; Zhang, Yiran; Wang, Linxiao; Jiang, Shasha; Sun, Yan; Yu, Yan

Novel therapeutic strategies targeting resistance mechanisms in hematologic malignancies: from BCL2 inhibition to immunomodulatory approaches

针对血液系统恶性肿瘤耐药机制的新型治疗策略:从BCL2抑制到免疫调节方法

Han, Qianyu; Jiang, Shasha; Chen, Jirui; Xue, Lei

Global research landscape on nanotechnology in acute lung injury: a bibliometric analysis

全球纳米技术在急性肺损伤领域的研究现状:文献计量分析

Zhang, Jian; Jiang, Shasha; Jiang, Jipeng; Liu, Yang

Maritoclax Overcomes FBW7 Deficiency-Driven Irinotecan Resistance in Colorectal Cancer by Targeting MCL1

Maritoclax 通过靶向 MCL1 克服结直肠癌中由 FBW7 缺陷引起的伊立替康耐药性

Qian Lin,Shuting Liu,Hongfei Jiang,Shasha Wang,Yixin Duan

Increased perfluorooctanoic acid accumulation facilitates the migration and invasion of lung cancer cells via remodeling cell mechanics.

全氟辛酸的积累增加通过重塑细胞力学促进肺癌细胞的迁移和侵袭

Mei Jie, Jiang Jipeng, Li Zhao, Pan Yue, Xu Ke, Gao Xinglong, Yuan Jing, Li Lili, Wang Yufei, Wang Liuxiang, Zhao Ailin, Jiang Shasha, Wang Xinlian, Yi Shaoqiong, Li Shilin, Xue Yueguang, Ma Yongfu, Liu Yang, Wang Yawei, Li Juan, Chen Chunying, Liu Ying

FGL2(172-220) peptides improve the antitumor effect of HCMV-IE1mut vaccine against glioblastoma by modulating immunosuppressive cells in the tumor microenvironment

FGL2(172-220)肽通过调节肿瘤微环境中的免疫抑制细胞,增强HCMV-IE1mut疫苗对胶质母细胞瘤的抗肿瘤作用。

Wang, Shan; Jiang, Shasha; Li, Xu; Huang, Huan; Qiu, Xu; Yu, Meng; Yang, Xiaoli; Liu, Fengjun; Wang, Chen; Shen, Wen; Wang, Yunyang; Wang, Bin